Mar 20, 2024

Guidance Documents for Rare Disease Drug Development

Read more

Mar 19, 2024

2024 Update on Classification, Etiology, and Typing of Renal Amyloidosis: A Review

Read more

Mar 18, 2024

Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management

Read more

Mar 13, 2024

Alnylam Launches Hereditary ATTR (hATTR) Amyloidosis Campaign to Help Shorten Time to Diagnosis for Inherited and Rapidly Progressive Disease

Read more

Feb 29, 2024

Consensus recommendations on holistic care in hereditary ATTR amyloidosis: an international Delphi survey of patient advocates and multidisciplinary healthcare professionals

Read more

Feb 28, 2024

Cardiac Amyloidosis: Emerging Diagnostic and Treatment Approaches

Read more

Feb 14, 2024

FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient’s Voice in Medical Product Development and Regulatory Decision Making

Read more

Feb 10, 2024

Needs of amyloidosis patients and their care providers: design & first results of the AMY-NEEDS research and care program

Read more

Feb 06, 2024

Impact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy

Read more

Feb 05, 2024

Multiorgan Dysfunction and Associated Prognosis in Transthyretin Cardiac Amyloidosis

Read more

Subscribe to